Desmoteplase in Acute Ischemic Stroke (DIAS)

尚未翻譯 尚未翻譯
类别 Primary study
Registry of Trialsclinicaltrials.gov
Year 2001

This article is not included in any systematic review

This article is part of the following publication threads:
  • DIAS [Desmoteplase in Acute Ischemic Stroke] (3 documents)
Loading references information
The DIAS study (Part 2) was performed to support the dose finding of desmoteplase treatment in subjects with acute ischemic stroke selected by perfusion/diffusion mismatch on MRI within a time window of 3 to 9 h after stroke-symptom onset. In addition, it assessed safety and tolerability of 3 doses of desmoteplase compared with placebo with special consideration of intracranial hemorrhage and major systemic bleedings.
Epistemonikos ID: 7e0a0ca7a8e4601b9f1ac7bf4b01250470d2ccc7
First added on: Apr 02, 2016